Leading Experts in Niaspan Prescribers for Raising HDL

Hossein Ardehali, Associate Professor, Northwestern University, Feinberg School of MedicineHossein Ardehali

Associate Professor
Northwestern University, Feinberg School of Medicine

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Hossein Ardehali, MD, PhD, is an Associate Professor of Medicine at Northwestern University in Illinois. His specialties include lipid metabolism, preventive cardiology, electrophysiology and heart failure. Dr. Ardehali's basic science research is in...

Harold Bays, President and Medical Director, L-MARC Research CenterHarold Bays

President and Medical Director
L-MARC Research Center

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all...

Bernard Chaitman, Professor and Director of Cardiovascular Research, SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINEBernard Chaitman

Professor and Director of Cardiovascular Research
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal...

Carlos Dujovne, Affiliate Professor of Medicine, OREGON HEALTH & SCIENCE UNIVERSITY - CCCarlos Dujovne

Affiliate Professor of Medicine
OREGON HEALTH & SCIENCE UNIVERSITY - CC

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Carlos Dujovne is an Affiliate Professor of Medicine, CV Division, Director, Clinical Cardiovascular-Metabolic Risk Treatment, and Prevention Programs at Oregon Health and Science University, Portland, OR. He is Board Certified/qualified, Internist, Gastroenterologist,...

Charles Glueck, Director of Cholesterol Center, Jewish HospitalCharles Glueck

Director of Cholesterol Center
Jewish Hospital

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Charles Glueck, MD, is the Director of Jewish Hospital Cholesterol Center in Cincinnati, Ohio. He has expertise in lipids, lipoproteins, atherosclerosis-thrombosis, thrombosis, human genetics, epidemiology, obstetrics and gynecology and hematology. Dr....

Ronald Innerfield, Vice President of Clinical Affairs, Evidence Based Medicine, Inc.Ronald Innerfield

Vice President of Clinical Affairs
Evidence Based Medicine, Inc.

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Ronald Innerfield, MD, FACE, is Chief of Clinical Trials and Epidemiology, Emeritus, at the Dorothy Bullock Memorial National Diabetes Center. He is also Vice President of Clinical Affairs of Evidence Based Medicine, a site management organization (SMO)...

Stefan Schreiber

Professor
CHRISTIAN ALBRECHTS UNIVERSITAT ZU KIEL

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Stefan Schreiber, MD, is Professor of Medicine and Gastroenterology at the Christian-Albrechts-University in Germany. Dr. Schreiber is responsible for designing, organizing, and conducting phase IB-III clinical trials of novel drugs for inflammatory bowel...

Dan Streja, Clinical Professor of Medicine, UNIVERSITY OF CALIFORNIA, LOS ANGELESDan Streja

Clinical Professor of Medicine
UNIVERSITY OF CALIFORNIA, LOS ANGELES

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Dan Streja, MD, is Clinical Professor of Medicine at the University of California, Los Angeles. He is also Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic, the Diabetes Clinic, and the divisions of Cardiology and Endocrinology at...

Howard Weintraub

Clinical Director
NEW YORK UNIVERSITY (INC)

          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub...

Page : 11 to 9 of 9

Leading institutions connect with members of the Healthcare councils through GLG